Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
Entering the ‘battle’ between precision and evidence-based medicine
Entering the ‘battle’ between precision and evidence-based medicine

Comprehensive information about specific gene variants and their impact on diagnosis and treatment is now available in an easily searchable database – it’s time to get to grips with genomics
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
1. Taylor C. ‘A battle is looming’ - GP urges docs to join the genomics revolution. www.nzdoctor.co.nz/article/news/battle-looming-gp-urges-docs-join-genomics-revolution
2. Medsafe. Pharmacogenomics – helps reduce rash decisions. Prescriber Update 2018:39(2);25–27. https://bit.ly/2M4k9kR
3. Whirl-Carrillo M, McDonagh EM, Hebert JM et al. Pharmacogenomics knowledge for personalized medicine. Clin Pharmacol Ther 2012;92(4):414–17.
4. Rademaker M. Drug hypersensitivity syndrome. DermNet NZ 2004, updated 2016. www.dermnetnz.org
5. Keller SF, Lu N, Blumenthal KG et al. Racial/ethnic variation and risk factors for allopurinol-associated severe cutaneous adverse reactions: a cohort study. Ann Rheum Dis 2018; doi: 10.1136/annrheumdis-2017-212905 (Epub ahead of print)